0      0

2021 AABB Annual Meeting On-Demand

AM21-15: Pediatric Cellular Therapy: An Overview from Collections to Alpha/Beta Depletions

Oct 17, 2021 6:00pm ‐ Oct 17, 2021 7:00pm

Credits: None available.

Members: $20.00
Standard: $25.00


Pediatric advanced therapies are an exciting, complex and evolving field. Autologous collections require collaboration between flexible apheresis services and the clinical/research team for success, including quality and reducing error. Mobilization, collection and processing methods impact the final therapeutic product. For haploidentical hematopoietic cell transplantation, Alpha/Beta T-cell Depletion has transformed the approach to donor selection and significantly expanded availability. A modern approach is sophisticated ex vivo processing of the donor graft to remove those cells most responsible for causing GVHD. This session will present examples and discuss the ongoing therapeutic diversification and development in cellular therapy protocols, which will require international collaboration to improve standardization, efficiency, and quality.

To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.

Learning Objectives:
  • Describe the range of pediatric advanced therapies for which apheresis cell collections are undertaken
  • Identify issues which add to the complexity of the process for apheresis teams and which could be improved by international collaboration.
  • Describe how Alpha/Beta T-cell Depletion is performed
  • Contrast the pros/cons of in vivo and ex vivo T-cell depletion strategies in pediatric patients undergoing haploidentical HCT





  • Kyle Annen, DO : Consultant: Terumo BCT
  • Christopher Dvorak, MD : Nothing to Disclose
  • Helen New : Nothing to Disclose

Credits Available

AM21-15: Pediatric Cellular Therapy: An Overview from Collections to Alpha/Beta Depletions Evaluation

You must be logged in and own this session in order to post comments.